文献速递冠心病外科

566例微创冠状动脉旁路移植术后的长期生存、心血管与功能结局

Long-term survival, cardiovascular, and functional outcomes after minimally invasive coronary artery bypass grafting in 566 patients.
PubMed 文献 · J Thorac Cardiovasc Surg · 2023-08-06

单中心前瞻性随访566例接受微创冠状动脉旁路移植术患者,临床随访完成率100%(平均7.0±4.4年),12年生存率为82.2%±2.6%。远期问卷显示心绞痛超过加拿大心血管学会II级者12例(2.8%),心功能超过纽约心脏协会II级者19例(4.5%),超过98%患者无切口相关疼痛。

要点

  • 12年生存率为82.2%±2.6%,50%患者(283例)接受多支血管移植。
  • 远期心绞痛超过加拿大心血管学会II级者12例(2.8%),心功能超过纽约心脏协会II级者19例(4.5%)。
  • 超过98%患者无切口相关疼痛,作者认为对特定患者是安全持久的替代方案。

核心结论

  • 作者认为,对特定患者(包括多支冠状动脉病变),微创冠状动脉旁路移植术是胸骨正中切开冠状动脉旁路移植术安全且持久的替代方案,短期和长期结局良好,远期显著症状和切口疼痛比例低。

研究设计与样本

  • 单中心前瞻性随访研究,纳入17年间接受微创冠状动脉旁路移植术的患者566例,主要结局为生存,远期随访时通过问卷评估功能结局,采用多变量Cox比例风险模型分析主要结局的相关因素。

主要发现

  • 临床随访完成率100%(平均7.0±4.4年),存活患者中83.9%(427例)完成随访问卷;50%患者(283例)接受多支血管移植。
  • 全队列12年生存率为82.2%±2.6%。
  • 远期问卷中,心绞痛超过加拿大心血管学会II级者12例(2.8%),心功能超过纽约心脏协会II级者19例(4.5%),超过98%患者无切口相关疼痛。
  • Cox比例风险分析显示,随访期间死亡的相关因素包括高龄、外周血管疾病、既往心肌梗死、左心室功能不全、过去5年内癌症、术中输血和杂交血运重建。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Sternotomy has been the gold standard incision for surgical revascularization but may be associated with chronic pain and sternal malunion. Minimally invasive coronary artery bypass grafting allows for complete surgical revascularization through a small thoracotomy in selected patients. There is a paucity of long-term data, particularly functional outcomes, for patients who underwent minimally invasive coronary artery bypass grafting. METHODS: Patients (N = 566) who underwent minimally invasive coronary artery bypass grafting at a single institution over a 17-year period were prospectively followed. The primary outcome was survival. At late follow-up, patients were contacted for a questionnaire on functional outcomes. Multivariable Cox proportional hazard model identified correlates of the primary outcome. RESULTS: Clinical follow-up was complete for 100% of patients (mean 7.0 ± 4.4 years); a follow-up questionnaire was also completed for 83.9% (N = 427) of live patients. Fifty percent of patients (N = 283) had undergone multivessel grafting. At 12 years, survival for the entire cohort was 82.2% ± 2.6%. On late follow-up questionnaire, 12 patients (2.8%) had greater than Canadian Cardiovascular Score Class II angina and 19 patients (4.5%) had greater than New York Heart Association Class II symptoms. More than 98% of patients did not have pain related to the incision site. Cox proportional hazards analysis identified older age, peripheral vascular disease, prior myocardial infarction, left ventricular dysfunction, cancer in the past 5 years, intraoperative transfusion, and hybrid revascularization as correlates of mortality during follow-up. CONCLUSIONS: Minimally invasive coronary artery bypass grafting is a safe and durable alternative to sternotomy coronary artery bypass grafting in selected patients, with excellent short- and long-term outcomes, including for multivessel coronary disease. At long-term follow-up, the proportion of patients with significant symptoms and incisional pain was low.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Guo MH, Toubar O, Issa H, et al. Long-term survival, cardiovascular, and functional outcomes after minimally invasive coronary artery bypass grafting in 566 patients. J Thorac Cardiovasc Surg. 2023. PMID: 37544476. doi:10.1016/j.jtcvs.2023.07.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。